ADIPOGENIX, INC.

Company Information
Address ADIPOGENIX, INC.
801 ALBANY ST, S112
BOSTON, MA, 02119 0251


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. New Agents That Inhibit Fatty Acid Accumulation

    Amount: $723,344.00

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Existing treatments for obesity are only ...

    SBIRPhase II2004Department of Health and Human Services
  2. New Agents That Inhibit Fatty Acid Accumulation

    Amount: $99,894.00

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Although weight loss is the most effectiv ...

    SBIRPhase I2003Department of Health and Human Services
  3. Activators of Adipocyte Fatty Acid Oxidation

    Amount: $99,944.00

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Existing drug and dietary treatments for ...

    SBIRPhase I2003Department of Health and Human Services
  4. SECRETED PROTEIN FROM ADIPOCYTES AND PREADIPOCYTES

    Amount: $99,820.00

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. While weight loss is the most effective t ...

    SBIRPhase I2002Department of Health and Human Services
  5. Anti-obesity drug development using human preadipocytes

    Amount: $0.00

    N/A

    SBIRPhase I2001Department of Health and Human Services
  6. Anti-obesity drug development using human preadipocytes

    Amount: $602,471.00

    N/A

    SBIRPhase II2001Department of Health and Human Services
  7. N/A

    Amount: $99,930.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  8. ENHANCED DIFFERENTIATION OF HUMAN PREADIPOCYTES

    Amount: $99,972.00

    Not Available The objective of Phase I is to develop and demonstrate a neural networks system to predict, map, and interpolate rotorcraft ground noise exposure data. It is well-known that the relat ...

    SBIRPhase I1999Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government